
Success Stories
Odyssey Therapeutics Climbs 11% After $304 Million IPO
Odyssey Therapeutics climbs 11% after a $304 million US IPO, signaling strong investor confidence in its innovative ther…
Marcus Rivera·
2 articles

Odyssey Therapeutics climbs 11% after a $304 million US IPO, signaling strong investor confidence in its innovative ther…

FDA approves the first gene therapy for genetic hearing loss on May 9, 2026, marking a significant advance in treating i…